BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 5080345)

  • 21. [Influence of chloroquine on the hexachlorobenzene-induced porphyria. Investigations in the skin, liver, and urine (author's transl)].
    Vizethum W; Bolsen K; Simon K; Weber K; Goerz G
    Arch Dermatol Res; 1980; 267(2):123-30. PubMed ID: 7406527
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Results of chloroquine therapy in seven cases of porphyria cutanea tarda: influence on clinical and chemical-clinical pictures (author's transl)].
    Arbosti G; Nava C; Ghezzi I; Grisler R; Brambilla G
    Med Lav; 1979; 70(3):239-47. PubMed ID: 470825
    [No Abstract]   [Full Text] [Related]  

  • 23. [Porphyria erythropoietica congenita Günther and chloroquine (author's transl)].
    Ippen H; Tillmann W; Seubert S; Seubert A
    Klin Wochenschr; 1978 Jun; 56(12):623-4. PubMed ID: 682527
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Two cases of infantile porphyria cutanea tarda: successful treatment with oral S-adenosyl-L-methionine and low-dose oral chloroquine.
    Battle AM; Stella AM; De Kaminsky AR; Kaminsky C; Mariano HG
    Br J Dermatol; 1987 Mar; 116(3):407-15. PubMed ID: 3567077
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [2 years' experience with combined therapy of symptomatic liver porphyria using pyrimethamine and chloroquine].
    Kaláb M; Cervinka J; Kotal P; Jirsa M; Kordac V; Marecek Z; Soldátová H; Papezová P
    Cas Lek Cesk; 1988 Mar; 127(10):305-9. PubMed ID: 3365727
    [No Abstract]   [Full Text] [Related]  

  • 26. Low-dose oral chloroquine in the treatment of porphyria cutanea tarda.
    Ashton RE; Hawk JL; Magnus IA
    Br J Dermatol; 1984 Nov; 111(5):609-13. PubMed ID: 6498093
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Experimental study of the action of antimalarial agents with respect to therapy in porphyria. Combined effect of chloroquine and pyrimethamine].
    Kotal P; Jirsa M; Kaláb M; Kordac V
    Cas Lek Cesk; 1989 Jan; 128(3):87-9. PubMed ID: 2655915
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Iron metabolism and its responses to allopurinol treatment in porphyria cutanea tarda.
    Burger T; Horváth T; Jávor T
    Acta Med Acad Sci Hung; 1978; 35(2):115-27. PubMed ID: 742338
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Influence of griseofulvin treatment on liver function and porphyrine metabolism].
    Simon N; Berkó G; Pólay A; Kocsis G
    Arch Dermatol Forsch; 1971; 241(2):148-55. PubMed ID: 4255210
    [No Abstract]   [Full Text] [Related]  

  • 30. Study of the effects of certain drugs on experimental porphyria in rats.
    Deshpande SG; Kandhari KC; Narang BS; Bikhchandani R; Bhutani LK
    Dermatologica; 1977; 154(5):284-90. PubMed ID: 863070
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Porphyria cutanea tarda due to ferrous gluconate.
    Ginsburg AD; Margesson LJ; Feleki K
    CMAJ; 1990 Oct; 143(8):747-9. PubMed ID: 2207938
    [No Abstract]   [Full Text] [Related]  

  • 32. [Porphyria cutanea tarda: possible treatment and its results (author's transl)].
    Goerz G; Krieg T
    Dtsch Med Wochenschr; 1978 Aug; 103(34):1329-33. PubMed ID: 308001
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Photosensitivity after treatment of porphyria cutanea tarda with low dose chloroquine.
    Gould P
    Br J Dermatol; 1978 Feb; 98(2):225-8. PubMed ID: 629877
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The treatment of cutaneous porphyria with chloroquine or D-penicillamine.
    Hunter GA; Donald GF
    Br J Dermatol; 1970 Dec; 83(6):702-3. PubMed ID: 5492482
    [No Abstract]   [Full Text] [Related]  

  • 35. Phlebotomy therapy in cutaneous porphyria. Effect on iron and trace metals.
    Walsh JR; Lobitz WC; Mahler DJ; Kingery FA
    Arch Dermatol; 1970 Feb; 101(2):167-72. PubMed ID: 5413253
    [No Abstract]   [Full Text] [Related]  

  • 36. [Combination therapy of porphyria cutanea tarda using chloroquine and bloodletting therapy].
    Horkay I; Nagy E
    Z Hautkr; 1980 Jun; 55(12):813-6. PubMed ID: 7415362
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Letter: Retreatment with chloroquine in porphyria cutanea tarda.
    Kowertz MJ
    JAMA; 1975 Jul; 233(1):22. PubMed ID: 1173413
    [No Abstract]   [Full Text] [Related]  

  • 38. Erythropoietin as treatment of haemodialysis-related porphyria cutanea tarda.
    Piazza V; Villa G; Galli F; Segagni S; Bovio G; Poggio F; Picardi L; Bianco L; Salvadeo A; Barosi G
    Nephrol Dial Transplant; 1992; 7(5):438-42. PubMed ID: 1321381
    [No Abstract]   [Full Text] [Related]  

  • 39. Chloroquine in the treatment of porphyria cutanea tarda.
    Tsega E; Besrat A; Damtew B; Seyoum E; Landells JW
    Trans R Soc Trop Med Hyg; 1981; 75(3):401-4. PubMed ID: 7324107
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Effect of chloroquine in porphyria cutanea tarda].
    Herrero C; Muniesa A
    Med Cutan Ibero Lat Am; 1980; 8(4-6):139-45. PubMed ID: 7024672
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.